CLINICAL ROLE -
Inflammatory Bowel Disease Drugs May Increase Leukemia Risk
Thiopurines found to increase the risk of myeloid disorders.
Read More
Therapy in Development for Different Ebola Strains
Researchers seek to get ahead of potential future Ebola outbreaks.
Protein May Block Release of Ebola Virus, HIV
TIM-family proteins may be able to block a wide range of viral infections.
ZMapp Reverses Ebola Infection in Animal Testing
Experimental drug results in 100% recovery in primates up to 5 days following infection.
HIV Drug May Not be as Effective in Some African Americans
A protein found in nearly half of African Americans speeds removal of medication from the body.
New Multiple Sclerosis Drug May Reverse Nerve Damage
Phase I study deems treatment safe and tolerable in humans.
Human Testing on Ebola Vaccine Will Begin Next Week
Treatment co-developed by National Institutes of Health and GlaxoSmithKline gets fast-tracked as World Health Organization issues dire prediction.
Ebola Infects ‘Unprecedented' Number of Health Care Workers
Limitations in available staff and protective equipment put medical personnel at increased risk.
FDA Approves New Blood Disorder Treatment
First-in-class treatment option available for severe aplastic anemia patients who had insufficient responses to immunosuppressive therapy.
Liberian Doctor Treated with Experimental Ebola Drug ZMapp Dies
Efficacy of treatment still undetermined as World Health Organization raises cost of battle strategy.
Work Continues on New Ebola Drugs as Second Outbreak Hits Africa
A different Ebola strain reported in Congo as researchers race to find a vaccine.
A different Ebola strain reported in the Congo as researchers race to find a vaccine.
Aurora Partners with Armada to Deliver Added Pharmacy Capabilities to Specialty Patients
Aurora to utilize enhanced therapy management services with Armada's ReachRx Online Therapy Management system.
Early Combination Treatment Reduces HIV Viral Load in Infants, But Still Not a Cure
Ceasing treatment may be the only way to determine whether HIV is cured, but doing so carries long-term risks.
Bioethicists: With Limited Supply of Ebola Drugs, Strengthening Health Systems Should Be a Priority
Doctors say experimental drugs should not be limited to well-off patients.
Study finds that ceasing treatment may be the only way to determine if the disease is cured, but doing so carries long-term risks.
Doctors say experimental Ebola drugs should not be limited to well-off patients.
Experimental Drug Protects Against Virus Similar to Ebola
Promising treatment protects nonhuman primates from Marburg virus up to 3 days after infection.
Orphan Drug Costs Continue to Push Spending Limits
Savings from biosimilars may not offer much relief due to development and manufacturing costs, according to Catamaran report.
Relief Group Calls Ebola Response Inadequate While American Patients Get Tested for Possible Exposure
Doctors Without Borders said virus cannot be contained without massive mobilization of resources to West Africa.
FDA Approves New Treatment for Rare Genetic Disease
Genzyme's eliglustat offers long-term treatment for Type 1 Gaucher disease.
The FDA has granted approval to Genzyme's eliglustat (Cerdelga), the only first-line oral therapy for patients with Type 1 Gaucher disease.
Doctors Without Borders says virus cannot be contained without massive mobilization of resources to West Africa.